tm
Seeing Is Believing
tm
Seeing Is Believing
NMRD is currently covered by 2 analysts with an average price target of $2.41. This is a potential upside of $2.41 (0%) from yesterday's end of day stock price of $0.
Nemaura Medical's activity chart (see below) currently has 1 price targets and 6 ratings on display. The stock rating distribution of NMRD is 100% BUY.
Highest price target for NMRD is $4, Lowest price target is $1, average price target is $2.41.
Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 21-Aug-2023. First documented stock forecast 03-Dec-2021.
Currently out of the existing stock ratings of NMRD, 5 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$2.5
$2.4 (2400.00%)
1 years 4 months 14 days ago
(21-Aug-2023)
0/3 (0%)
$1.74 (228.95%)
Buy
$4
$3.9 (3900.00%)
$7.5
1 years 5 months 18 days ago
(17-Jul-2023)
0/2 (0%)
$3.08 (334.78%)
What is NMRD (Nemaura Medical) average time for price targets to be met?
Which analyst has the current highest performing score on NMRD (Nemaura Medical) with a proven track record?
Which analyst has the current lower performing score on NMRD (Nemaura Medical) with a proven track record?
Which analyst has the most public recommendations on NMRD (Nemaura Medical)?
Which analyst is the currently most bullish on NMRD (Nemaura Medical)?
Which analyst is the currently most reserved on NMRD (Nemaura Medical)?
